Literature DB >> 18337379

Mice with pulmonary tuberculosis treated with Mycobacterium vaccae develop strikingly enhanced recall gamma interferon responses to M. vaccae cell wall skeleton.

Elisabeth Rodríguez-Güell1, Gemma Agustí, Mercè Corominas, Pere-Joan Cardona, Marina Luquin, Esther Julián.   

Abstract

Whole heat-killed Mycobacterium vaccae is used as an immunotherapeutic agent in tuberculosis (TB), but the compound(s) that triggers its immunostimulatory ability is not known. Here, we show that among different subcellular fractions, the cell wall skeleton induced a prominent expression of gamma interferon in splenocytes from both non-TB and TB M. vaccae-treated mice.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18337379      PMCID： PMC2394841          DOI： 10.1128/CVI.00477-07

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN： 1556-679X


  14 in total

Review 1.  Immunotherapy with Mycobacterium vaccae in the treatment of mycobacterial disease.

Authors:  J L Stanford
Journal:  J Infect       Date:  1999-11       Impact factor: 6.072

2.  Production of antibodies against glycolipids from the Mycobacterium tuberculosis cell wall in aerosol murine models of tuberculosis.

Authors:  P J Cardona; E Julián; X Vallès; S Gordillo; M Muñoz; M Luquin; V Ausina
Journal:  Scand J Immunol       Date:  2002-06       Impact factor: 3.487

3.  Pathogenesis of tuberculosis in mice exposed to low and high doses of an environmental mycobacterial saprophyte before infection.

Authors:  R Hernandez-Pando; L Pavön; K Arriaga; H Orozco; V Madrid-Marina; G Rook
Journal:  Infect Immun       Date:  1997-08       Impact factor: 3.441

4.  The ability of heat-killed Mycobacterium vaccae to stimulate a cytotoxic T-cell response to an unrelated protein is associated with a 65 kilodalton heat-shock protein.

Authors:  M A Skinner; R Prestidge; S Yuan; T J Strabala; P L Tan
Journal:  Immunology       Date:  2001-02       Impact factor: 7.397

5.  Interactions between hormone-mediated and vaccine-mediated immunotherapy for pulmonary tuberculosis in BALB/c mice.

Authors:  R Hernandez-Pando; L Pavon; E H Orozco; J Rangel; G A Rook
Journal:  Immunology       Date:  2000-07       Impact factor: 7.397

6.  Suppression of airway eosinophilia by killed Mycobacterium vaccae-induced allergen-specific regulatory T-cells.

Authors:  Claudia Zuany-Amorim; Elzbieta Sawicka; Corinne Manlius; Alain Le Moine; Laura R Brunet; David M Kemeny; Gareth Bowen; Graham Rook; Christoph Walker
Journal:  Nat Med       Date:  2002-06       Impact factor: 53.440

Review 7.  Immunotherapy with Mycobacterium vaccae in the treatment of tuberculosis.

Authors:  John Stanford; Cynthia Stanford; John Grange
Journal:  Front Biosci       Date:  2004-05-01

8.  Mycobacterium vaccae induces a population of pulmonary CD11c+ cells with regulatory potential in allergic mice.

Authors:  Victoria C Adams; Jon R F Hunt; Roberta Martinelli; Rebecca Palmer; Graham A W Rook; Laura Rosa Brunet
Journal:  Eur J Immunol       Date:  2004-03       Impact factor: 5.532

9.  Interferon gamma/IL10 ratio defines the disease severity in pulmonary and extra pulmonary tuberculosis.

Authors:  Bushra Jamil; Firdaus Shahid; Zahra Hasan; Nosheen Nasir; Tashmeem Razzaki; Ghaffar Dawood; Rabia Hussain
Journal:  Tuberculosis (Edinb)       Date:  2007-05-29       Impact factor: 3.131

10.  Maturation of human dendritic cells by cell wall skeleton of Mycobacterium bovis bacillus Calmette-Guérin: involvement of toll-like receptors.

Authors:  S Tsuji; M Matsumoto; O Takeuchi; S Akira; I Azuma; A Hayashi; K Toyoshima; T Seya
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441
View more
  5 in total

Review 1.  Recent advances in the development of vaccines for tuberculosis.

Authors:  Mohamed Jawed Ahsan
Journal:  Ther Adv Vaccines       Date:  2015-05

2.  Impaired gamma interferon response to Mycobacterium vaccae antigens in patients with cavitary pulmonary tuberculosis.

Authors:  Elisabeth Rodríguez-Güell; Gemma Agustí; Mercè Corominas; Marina Luquin; Esther Julián
Journal:  Clin Vaccine Immunol       Date:  2008-07-02

3.  Effects of Mycobacterium vaccae vaccine in a mouse model of tuberculosis: protective action and differentially expressed genes.

Authors:  Wen-Ping Gong; Yan Liang; Yan-Bo Ling; Jun-Xian Zhang; You-Rong Yang; Lan Wang; Jie Wang; Ying-Chang Shi; Xue-Qiong Wu
Journal:  Mil Med Res       Date:  2020-06-03

Review 4.  Therapeutic Vaccines for Tuberculosis: An Overview.

Authors:  Rania Bouzeyen; Babak Javid
Journal:  Front Immunol       Date:  2022-06-24       Impact factor: 8.786

5.  Efficacy of Mycobacterium indicus pranii immunotherapy as an adjunct to chemotherapy for tuberculosis and underlying immune responses in the lung.

Authors:  Ankan Gupta; Farhan J Ahmad; Faiz Ahmad; Umesh D Gupta; Mohan Natarajan; Vishwamohan Katoch; Sangeeta Bhaskar
Journal:  PLoS One       Date:  2012-07-26       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.